𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ki-1 positive meningeal lymphoma in a patient with a history of Hodgkin lymphoma

✍ Scribed by M. Serena; G. Tonetto; P. Belli


Publisher
Springer Milan
Year
1991
Tongue
English
Weight
649 KB
Volume
12
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Paraneoplastic pemphigus in a patient wi
✍ Plumb, Renee; Doolittle, Gary C. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 2 views

Paraneoplastic pemphigus (PNP) is an autoimmune disorder occurring in the setting of an underlying neoplasm in which patients have polymorphous skin and mucous membrane lesions. We describe a patient with non-Hodgkin's lymphoma who developed bullous, ulcerating lesions in an area being treated with

Systemic Hodgkin’s lymphoma in a patient
✍ J.J. Scarisbrick; F. Child; M. Spittle; E. Calonje; R. Russell-Jones 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB

We report a case of a 71-year-old male with Sézary syndrome diagnosed in 1996 who subsequently developed systemic Hodgkin's lymphoma. His only past treatment was bath psoralen plus ultraviolet A. He has since been treated with multiagent chemotherapy (ChlVPP/PABLOE) which induced a remission in his

Specific skin lesions occurring in a pat
✍ John A Pagliaro; Stephen I White 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

A 47‐year‐old man presented with a several month history of non‐specific acquired ichthyosis, an unknown period of generalized lymphadenopathy and a short history of erythematous papules and nodules affecting the cutaneous drainage area of his right axillary lymph nodes. Histology confirmed these le

Response of myasthenia gravis to rituxim
✍ Ajeet Gajra; Neerja Vajpayee; Sara J. Grethlein 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

## Abstract Myasthenia gravis is a B‐cell‐mediated autoimmune neuromuscular disorder characterized by weakness and fatigability of skeletal muscles. The underlying defect is an autoantibody‐mediated attack on the acetylcholine receptors (AchRs) at the neuromuscular junction. Rituximab is a genetica